Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premal Patel

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Urology|April 15, 2026
The SUMMIT Study: A real-world, clinical study to evaluate the performance of the Optilume® BPH Catheter System in men with symptomatic Benign Prostatic Hyperplasia (BPH)Mário Henrique Bitar Siqueira, Omar Buksh, Abbas Hammoud, et al.
CVIR Endovascular|August 10, 2024
Interventional solutions for post-surgical problems: a lymphatic leaks reviewFernando M Gómez, Tarik R Baetens, Ernestos Santos, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 4, 2021
Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&AEthan D Grober, Yonah Krakowsky, Mohit Khera, et al.
Investigational New Drugs|August 2, 2020
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumorsGeoffrey I Shapiro, Patricia LoRusso, Daniel C Cho, et al.
CVIR Endovascular|September 17, 2024
Correction: Interventional solutions for post‑surgical problems: a lymphatic leaks reviewFernando M Gómez, Tarik R Baetens, Ernestos Santos, et al.
Urology|April 5, 2016
Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term OutcomesJasmir G Nayak, Premal Patel, Olli Saarela, et al.
Journal of Endourology|April 7, 2017
A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell CarcinomaPremal Patel, Jasmir G Nayak, Zhihui Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 27, 2019
Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large, Canadian, multi-institutional databaseJustin D Oake, Premal Patel, Luke T Lavallée, et al.
Urology|November 3, 2023
Evaluating Patient Tolerability for Urological Procedures Under Conscious Sedation: A Prospective StudyKapilan Panchendrabose, Dhiraj S Bal, Andrew Pierce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignanciesRavi Salgia, Premal Patel, John Bothos, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Urology|April 15, 2026
The SUMMIT Study: A real-world, clinical study to evaluate the performance of the Optilume® BPH Catheter System in men with symptomatic Benign Prostatic Hyperplasia (BPH)Mário Henrique Bitar Siqueira, Omar Buksh, Abbas Hammoud, et al.
CVIR Endovascular|August 10, 2024
Interventional solutions for post-surgical problems: a lymphatic leaks reviewFernando M Gómez, Tarik R Baetens, Ernestos Santos, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 4, 2021
Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&AEthan D Grober, Yonah Krakowsky, Mohit Khera, et al.
Investigational New Drugs|August 2, 2020
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumorsGeoffrey I Shapiro, Patricia LoRusso, Daniel C Cho, et al.
CVIR Endovascular|September 17, 2024
Correction: Interventional solutions for post‑surgical problems: a lymphatic leaks reviewFernando M Gómez, Tarik R Baetens, Ernestos Santos, et al.
Urology|April 5, 2016
Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term OutcomesJasmir G Nayak, Premal Patel, Olli Saarela, et al.
Journal of Endourology|April 7, 2017
A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell CarcinomaPremal Patel, Jasmir G Nayak, Zhihui Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 27, 2019
Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large, Canadian, multi-institutional databaseJustin D Oake, Premal Patel, Luke T Lavallée, et al.
Urology|November 3, 2023
Evaluating Patient Tolerability for Urological Procedures Under Conscious Sedation: A Prospective StudyKapilan Panchendrabose, Dhiraj S Bal, Andrew Pierce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignanciesRavi Salgia, Premal Patel, John Bothos, et al.
Pageof 17